menu search

HQY / Down -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)

Down -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)
HealthEquity (HQY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Read More
Posted: Nov 3 2023, 11:18
Author Name: Zacks Investment Research
Views: 030180

HQY News  

Down -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)

By Zacks Investment Research
November 3, 2023

Down -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)

HealthEquity (HQY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with str more_horizontal

HealthEquity (HQY) Up 4% Since Last Earnings Report: Can It Continue?

By Zacks Investment Research
October 5, 2023

HealthEquity (HQY) Up 4% Since Last Earnings Report: Can It Continue?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? more_horizontal

HealthEquity (HQY) to Add Conduent's HSA Accounts in 2024

By Zacks Investment Research
September 26, 2023

HealthEquity (HQY) to Add Conduent's HSA Accounts in 2024

HealthEquity (HQY) is set to receive the Conduent's HSA portfolio as a part of an agreement signed by the companies earlier this month. The deal is li more_horizontal

HealthEquity (HQY) Surpasses Q2 Earnings Estimates, FY24 View Up

By Zacks Investment Research
September 6, 2023

HealthEquity (HQY) Surpasses Q2 Earnings Estimates, FY24 View Up

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the second quarter of fiscal 2024. more_horizontal

HealthEquity, Inc. (HQY) Q2 2024 Earnings Call Transcript

By Seeking Alpha
September 5, 2023

HealthEquity, Inc. (HQY) Q2 2024 Earnings Call Transcript

HealthEquity, Inc. (NASDAQ:HQY ) Q2 2024 Earnings Conference Call September 5, 2023 4:30 PM ET Company Participants Richard Putnam - Investor Relation more_horizontal

HealthEquity (HQY) Beats Q2 Earnings and Revenue Estimates

By Zacks Investment Research
September 5, 2023

HealthEquity (HQY) Beats Q2 Earnings and Revenue Estimates

HealthEquity (HQY) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earn more_horizontal

Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics

By Zacks Investment Research
September 5, 2023

Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2023, it could be w more_horizontal

Is HealthEquity (HQY) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
September 4, 2023

Is HealthEquity (HQY) Outperforming Other Medical Stocks This Year?

Here is how HealthEquity (HQY) and InMode (INMD) have performed compared to their sector so far this year. more_horizontal


Search within

Pages Search Results: